Breaking News, Promotions & Moves

Nucleus RadioPharma Names Mark Przekop COO

Przekop brings over 35 years of industry experience in nuclear pharmacy and radiopharmaceuticals.

Nucleus RadioPharma, a development, manufacturing, and supply chain organization for radiopharmaceuticals, has appointed Mark Przekop chief operating officer. Przekop is an industry veteran with over 35 years of experience in the nuclear pharmacy and radiopharmaceuticals industry. He also brings extensive commercial and operational experience in expanding supply chain networks, marketing, and regulatory compliance oversight.

Prior to joining Nucleus, Przekop held multiple roles at ARTMS, Inc., most recently as chief operating officer responsible for overseeing supply chains for business operations, product development and chemistry teams, managing regulatory strategy for the ARTMS portfolio, and cultivating business partnerships with key U.S. nuclear pharmacy customers. He was also vice president of Pharmacy Services at Jubilant Radiopharma, where he oversaw the entire Eastern region.

“Mark’s experience and wealth of knowledge in business strategy, commercial manufacturing, and supply chain oversight in radiopharmaceuticals, as demonstrated by his impressive background in nuclear medicine is a perfect fit for us,” said Charles Conroy, CEO of Nucleus RadioPharma. “Over the past year, we’ve reached major milestones, including closing our recent oversubscribed $56 million Series A to greatly increase the accessibility of radiopharmaceuticals to cancer patients, and we look forward to leveraging Mark’s expertise in business strategy to continue bringing life-saving treatments to patients with cancer.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters